• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染与胃癌的流行病学演变

The evolving epidemiology of Helicobacter pylori infection and gastric cancer.

作者信息

Huang Jia-Qing, Hunt Richard H

机构信息

Department of Medicine, Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario L8N 3Z5, Canada.

出版信息

Can J Gastroenterol. 2003 Jun;17 Suppl B:18B-20B. doi: 10.1155/2003/692808.

DOI:10.1155/2003/692808
PMID:12845346
Abstract

The relationship between Helicobacter pylori infection and the risk of gastric cancer has been well established in the last decade. Four meta-analyses have found that the infection increases the risk of noncardia gastric cancer by 2- to 6-fold compared with noninfected control populations. However, the role of cagA strains of H pylori in relation to gastric cancer has not been evaluated systematically. We undertook a meta-analysis of epidemiological studies examining the relationship between infection with cagA-positive strains of H pylori and the risk of gastric cancer, and found that patients who are seropositive for cagA strains of H pylori are at an increased risk for developing noncardia gastric cancer compared with those with H pylori infection alone. Therefore, searching for cagA-positive strains of H pylori may help identify populations at a greater risk for developing gastric cancer.

摘要

在过去十年中,幽门螺杆菌感染与胃癌风险之间的关系已得到充分证实。四项荟萃分析发现,与未感染的对照人群相比,该感染使非贲门胃癌的风险增加了2至6倍。然而,幽门螺杆菌cagA菌株在胃癌方面的作用尚未得到系统评估。我们对流行病学研究进行了一项荟萃分析,以检验感染cagA阳性幽门螺杆菌菌株与胃癌风险之间的关系,结果发现,与仅感染幽门螺杆菌的患者相比,cagA菌株血清阳性的患者患非贲门胃癌的风险增加。因此,寻找cagA阳性幽门螺杆菌菌株可能有助于识别患胃癌风险更高的人群。

相似文献

1
The evolving epidemiology of Helicobacter pylori infection and gastric cancer.幽门螺杆菌感染与胃癌的流行病学演变
Can J Gastroenterol. 2003 Jun;17 Suppl B:18B-20B. doi: 10.1155/2003/692808.
2
Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.MCC-西班牙病例对照研究中胃癌风险的幽门螺杆菌血清生物标志物
Cancer Epidemiol. 2017 Oct;50(Pt A):76-84. doi: 10.1016/j.canep.2017.08.002. Epub 2017 Sep 7.
3
[Helicobacter pylori CagA(+) infection in gastric cancer patients].胃癌患者中的幽门螺杆菌CagA(+)感染
Pol Merkur Lekarski. 2002 Sep;13(75):216-20.
4
Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?幽门螺杆菌与胃癌之间的关联是否仅限于细胞毒素相关基因A(CagA)阳性菌株?
Helicobacter. 2004 Jun;9(3):271-7. doi: 10.1111/j.1083-4389.2004.00222.x.
5
Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.夏威夷的幽门螺杆菌、胃蛋白酶原与胃腺癌
J Infect Dis. 2005 Jun 15;191(12):2075-81. doi: 10.1086/430353. Epub 2005 May 11.
6
Meta-analysis of the relationship between cagA seropositivity and gastric cancer.cagA血清阳性与胃癌关系的Meta分析
Gastroenterology. 2003 Dec;125(6):1636-44. doi: 10.1053/j.gastro.2003.08.033.
7
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.幽门螺杆菌CagA+菌株的作用与胃癌和食管癌风险
Int J Cancer. 2003 Mar 1;103(6):815-21. doi: 10.1002/ijc.10887.
8
Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan.日本冲绳幽门螺杆菌cagA基因多样性与胃癌的关系
J Gastroenterol. 2006 Jul;41(7):668-73. doi: 10.1007/s00535-006-1838-6.
9
Seroprevalence of cytotoxin-associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in south China.中国南方胃癌高发地区长乐细胞毒素相关基因A阳性幽门螺杆菌菌株的血清流行率
Aliment Pharmacol Ther. 1999 Oct;13(10):1295-302. doi: 10.1046/j.1365-2036.1999.00619.x.
10
Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.幽门螺杆菌血清阳性与贲门胃癌和非贲门胃癌的相反风险。
J Natl Cancer Inst. 2006 Oct 18;98(20):1445-52. doi: 10.1093/jnci/djj393.

引用本文的文献

1
Gut microbiota shifts in patients with gastric cancer in perioperative period.胃癌患者围手术期肠道微生物群的变化。
Medicine (Baltimore). 2019 Aug;98(35):e16626. doi: 10.1097/MD.0000000000016626.
2
Is There a Role for the Non- Bacteria in the Risk of Developing Gastric Cancer?非细菌因素在胃癌发病风险中的作用?
Int J Mol Sci. 2018 May 3;19(5):1353. doi: 10.3390/ijms19051353.
3
Effect of coffee consumption on the risk of gastric cancer: a systematic review and meta-analysis of prospective cohort studies.咖啡消费对胃癌风险的影响:前瞻性队列研究的系统评价和荟萃分析
PLoS One. 2015 May 29;10(5):e0128501. doi: 10.1371/journal.pone.0128501. eCollection 2015.
4
Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.益生菌在幽门螺杆菌根除治疗中的应用:一项系统评价与荟萃分析。
World J Gastroenterol. 2015 Apr 14;21(14):4345-57. doi: 10.3748/wjg.v21.i14.4345.
5
Advances in the treatment of infection in children.儿童感染治疗的进展。
Ann Gastroenterol. 2015 Jan-Mar;28(1):10-18.
6
Nontraditional therapies to treat Helicobacter pylori infection.治疗幽门螺杆菌感染的非传统疗法。
J Microbiol. 2014 Apr;52(4):259-72. doi: 10.1007/s12275-014-3603-5. Epub 2014 Mar 29.
7
Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.筛查和治疗幽门螺杆菌预防胃癌的成本效益。
Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):933-47. doi: 10.1016/j.bpg.2013.09.005. Epub 2013 Sep 27.
8
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a systematic review of recent evidence.序贯疗法与标准三联疗法根除幽门螺杆菌的疗效比较:近期证据的系统评价。
Drugs. 2013 Jun;73(8):815-24. doi: 10.1007/s40265-013-0053-z.
9
Modified Sequential Therapy Regimen versus Conventional Triple Therapy for Helicobacter Pylori Eradication in Duodenal Ulcer Patients in China: A Multicenter Clinical Comparative Study.中国十二指肠溃疡患者中幽门螺杆菌根除的改良序贯治疗方案与传统三联疗法的多中心临床对比研究。
Gastroenterol Res Pract. 2012;2012:405425. doi: 10.1155/2012/405425. Epub 2011 Nov 21.
10
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.标准三联、果胶铋四联和序贯疗法根除幽门螺杆菌。
World J Gastroenterol. 2010 Sep 14;16(34):4357-62. doi: 10.3748/wjg.v16.i34.4357.